NKX3-2 has not been widely investigated in relation to tumor development and progression, with a few studies primarily describing its ability to facilitate gastric cancer metastasis [5] and the dysregulation of immune cell differentiation programs in B-cell lymphomas and T-cell acute lymphoblastic leukemia [6,7]. This evidence concerns the gene NKX3-2 and neoplasm.